Clinical Trial Update: Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating phenotypic drug probes as predictors of drug-drug interactions with tacrolimus in kidney transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Drug Interactions, Kidney Transplantation | Phase 4 | Status: COMPLETED